Mj. Ferrandiz et al., Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci, ANTIM AG CH, 43(10), 1999, pp. 2520-2523
Nine ciprofloxacin-resistant viridans group streptococci isolated from asym
ptomatic carriers were analyzed. Identification to the species level by usi
ng three different commercial systems and a PCR-based approach was inconsis
tent. The nucleotide sequences of fragments of the parC, parE, gyrA, and gy
rB genes showed considerable intra- and interspecies variations, and these
variations mainly involved silent mutations. Three isolates had changes in
Ser-79 of ParC (to Phe or Tyr). Phenotypic characterization indicated that
eight of the nine isolates had a putative efflux mechanism that would confe
r low-level resistance to ciprofloxacin.